trending Market Intelligence /marketintelligence/en/news-insights/trending/slab7i0oki3mw2iyptmcag2 content esgSubNav
In This List

Zynex appoints Aytu BioScience CEO to board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Zynex appoints Aytu BioScience CEO to board

Medical device maker Zynex Inc. appointed Joshua Disbrow as an independent board member.

Disbrow currently serves as the chairman and CEO of Colorado-based Aytu BioScience Inc.